UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782-787

2015

Volltextzugriff (PDF)

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome

Arthritis care & research (2010), 2010-03, Vol.62 (3), p.302-307

2010

Volltextzugriff (PDF)

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242

2010

Volltextzugriff (PDF)

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1767-1773

2009

Volltextzugriff (PDF)

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.910-920

2014

Volltextzugriff (PDF)

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.910-920

2014

Volltextzugriff (PDF)

AB0378 UPGRADING THERAPY STRATEGY IMPROVES PREGNANCY OUTCOME IN ANTIPHOSPHOLIPID SYNDROME: A COHORT MANAGEMENT STUDY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1489-1489

2020

Volltextzugriff (PDF)

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1693-1696

2008

Volltextzugriff (PDF)

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.529-532

2018

Volltextzugriff (PDF)

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1527-1531

2013

Volltextzugriff (PDF)

Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study

Clinical and experimental rheumatology, 2011-05, Vol.29 (3), p.551

2011

Volltextzugriff (PDF)

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Clinica chimica acta, 2018-10, Vol.485, p.74-78

2018

Volltextzugriff (PDF)

SAT0176 THERAPEUTIC APHERESIS DURING PREGNANCY IN RHEUMATIC DISEASES

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1029-1030

2020

Volltextzugriff (PDF)

Correct laboratory approach to APS diagnosis and monitoring

Autoimmunity reviews, 2013-06, Vol.12 (8), p.832-834

2013

Volltextzugriff (PDF)

Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy

Ultrasound in obstetrics & gynecology, 2016-08, Vol.48 (2), p.224-231

2016

Volltextzugriff (PDF)

APS - Diagnostics and challenges for the future

Autoimmunity reviews, 2016-11, Vol.15 (11), p.1031-1033

2016

Volltextzugriff (PDF)

Clinical and laboratory characteristics of isolated lupus anticoagulants

Thrombosis research, 2018-05, Vol.165, p.51-53

2018

Volltextzugriff (PDF)

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study

Annals of the rheumatic diseases, 2009-03, Vol.68 (3), p.397-399

2009

Volltextzugriff (PDF)

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy

Thrombosis research, 2009-01, Vol.123 (3), p.482-487

2009

Volltextzugriff (PDF)

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis research, 2015-07, Vol.136 (1), p.161-163

2015

Volltextzugriff (PDF)

POS0751 COMORBIDITY AND LONG-TERM OUTCOME IN PATIENTS WITH CONGENITAL HEART BLOCK: PRELIMINARY DATA OF THE ITALIAN REGISTRY ON THE IMMUNE-MEDIATED CONGENITAL HEART BLOCK

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.628-628

2021

Volltextzugriff (PDF)

Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome

Thrombosis and haemostasis, 2013-05, Vol.109 (5), p.901-908

2013

Volltextzugriff (PDF)

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome

Lupus, 2012-06, Vol.21 (7), p.787-789

2012

Volltextzugriff (PDF)

1 – 25 von 354

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(256)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(209)
Science & Technology
(200)
Life Sciences & Biomedicine
(196)
Female
(173)
Adult
(138)
Male
(106)
Middle Aged
(100)
Pregnancy
(78)
Rheumatology
(78)
Antiphospholipid Syndrome
(64)
Biological And Medical Sciences
(58)
Medical Sciences
(57)
Aged
(55)
Antiphospholipid Syndrome - Immunology
(50)
Thrombosis
(40)
Hematology
(38)
Antiphospholipid Antibodies
(37)
Immunology
(35)
Antiphospholipid Syndrome - Complications
(34)
Risk Factors
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies

AB0378 UPGRADING THERAPY STRATEGY IMPROVES PREGNANCY OUTCOME IN ANTIPHOSPHOLIPID SYNDROME: A COHORT MANAGEMENT STUDY

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

SAT0176 THERAPEUTIC APHERESIS DURING PREGNANCY IN RHEUMATIC DISEASES

Correct laboratory approach to APS diagnosis and monitoring

Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy

APS - Diagnostics and challenges for the future

Clinical and laboratory characteristics of isolated lupus anticoagulants

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

POS0751 COMORBIDITY AND LONG-TERM OUTCOME IN PATIENTS WITH CONGENITAL HEART BLOCK: PRELIMINARY DATA OF THE ITALIAN REGISTRY ON THE IMMUNE-MEDIATED CONGENITAL HEART BLOCK

Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome

Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome

Suchergebnisse filtern